Nutex Health Inc. NUTX

Rank #2372 · Nasdaq · $1.4B market cap

Audited by GRANT THORNTON LLP, no going-concern flag in the latest filing.

Score

21.7

P/E

-30.1

P/B

10.40

ROE

-34.6%

Op. Margin

-12.8%

Debt Ratio

352%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -30.1x, P/B 10.40x. Ranks in the top 78% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -34.6%. Ranks in the top 82% of the universe.

Safety ★☆☆☆☆

Weak

Debt ratio 352%. Ranks in the top 75% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆

Good

Revenue growth of 12.9% year over year. Ranks in the top 28% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2011	–	$-0.0B	$0.0B	–	–	–
2012	–	$-0.0B	$-0.0B	$0.0B	–	18
2013	–	$-0.0B	$-0.0B	$0.0B	–	144
2014	–	$-0.0B	$0.0B	$0.0B	–	93
2015	–	$-0.0B	$-0.0B	$-0.0B	–	-6352
2016	–	$-0.0B	$0.0B	$0.0B	–	389
2017	–	$-0.0B	$-0.0B	$0.0B	–	-67
2019	$0.0B	$-0.0B	$-0.0B	$-0.0B	-61.5	-195
2020	$0.0B	$-0.0B	$-0.0B	$-0.0B	-504.8	-323
2021	$0.0B	$0.0B	$-0.0B	$0.0B	86.6	70
2022	$0.3B	$0.2B	$0.1B	$0.1B	55.9	177
2023	$0.3B	$0.2B	$0.1B	$0.1B	51.4	325
2024	$0.2B	$-0.4B	$-0.4B	$0.1B	-185.4	519
2025	$0.2B	$-0.0B	$-0.0B	$0.1B	-12.8	352